Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Treating chronic hepatitis C in the primary care setting.

Thomas G McGinn1, Donald Gardenier, Lata K McGinn

  • 1Division of General Internal Medicine, The Mount Sinai School of Medicine, New York, NY 10029, USA. thomas.mcginn@mountsinai.org

Seminars in Liver Disease
|February 26, 2005
PubMed
Summary

Primary care providers can effectively manage uncomplicated chronic hepatitis C (HCV) infections. This model expands treatment access and improves patient outcomes by integrating HCV care into general medicine settings.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Justice in Multi-Organ Transplantation.

The American journal of bioethics : AJOB·2026
Same author

Imaging findings in Fontan-associated liver disease: Results of a single center study.

International journal of cardiology. Congenital heart disease·2026
Same author

High Incidence of Undiagnosed Hepatocellular Carcinoma in Transplant Recipients With Metabolic-Associated Steatotic Liver Disease.

Clinical transplantation·2026
Same author

Impact of Non-Malignant Portal Vein Thrombosis in Recipients with Metabolic Dysfunction-Associated Steatotic Liver Disease Compared to Other Transplant Indications.

Journal of clinical medicine·2026
Same author

A systematic review of post-liver transplantation treatment and outcomes for late T-cell mediated, chronic ductopenic, and antibody-mediated rejection.

Hepatology communications·2026
Same author

Liver Biopsy Features May Help Distinguish Drug-Induced Autoimmune-Like Hepatitis From Idiopathic Autoimmune Hepatitis.

Archives of pathology & laboratory medicine·2026

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Primary Care Medicine

Background:

  • The National Institutes of Health highlight the need for broader access to chronic hepatitis C virus (HCV) infection treatment.
  • A diverse patient population requires expanded treatment options for HCV.

Purpose of the Study:

  • To establish a program for identifying, treating, and referring patients with chronic hepatitis C.
  • To assess the feasibility and advantages of primary care-based HCV treatment.

Main Methods:

  • A collaborative program was developed by General Internal Medicine and Liver Diseases divisions.
  • Uncomplicated HCV cases were treated within the primary care setting.
  • Patients underwent a structured pretreatment evaluation and management of comorbidities.

Related Experiment Videos

Main Results:

  • Preliminary data indicate unique advantages of primary care-based HCV treatment.
  • The primary care setting facilitates comprehensive care and management of patient needs.
  • The program supports patient navigation through complex treatment processes.

Conclusions:

  • Primary care-based treatment models can increase hepatitis C (HCV) literacy among providers.
  • This approach extends HCV treatment to a wider patient population.
  • Integrating HCV care into primary settings offers a viable model for expanding access to care.